Recent Publications

• 1. Bawany F
  2. Tbakhi B
  3. Mendler JH
  4. Richardson CT
  5. Bennett JM
  6. Aljitawi OS
  Remission of anti-TIF1γ dermatomyositis after allogeneic hematopoietic stem cell transplant for myelodysplastic syndrome.; Blood advances; Vol 4(22). 2020 Nov 24.
• 1. Tbakhi B
  2. Furqan F
  3. Scott G
  4. Liesveld JL
  5. Aljitawi OS
  Autologous Stem Cell Rescue recipient with neutrophil tissue delivery detected prior to blood engraftment: a case report.; EJHaem; Vol 1(1). 2020 Jul.
• 1. Elad S
  2. Aljitawi O
  3. Zadik Y
  Oral graft-versus-host disease: a pictorial review and a guide for dental practitioners.; International dental journal. 2020 Jun 28.
• 1. Liesveld JL
  2. Sharma N
  3. Aljitawi OS
  Stem Cell Homing: From Physiology to Therapeutics.; Stem cells (Dayton, Ohio). 2020 Jun 11.
• 1. Mina A
  2. Aljitawi OS
  Use of hyperbaric oxygen in hematopoietic cell transplantation to aid post-transplant recovery.; Journal of comparative effectiveness research; Vol 9(3). 2020 Feb.
• 1. Abdelhakim H
  2. Shune L
  3. Bhatti S
  4. Cantilena AR
  5. Baran A
  6. Lin TL
  7. Ganguly S
  8. Singh AK
  9. Abhyankar S
  10. Divine C
  11. Lipe B
  12. McGuirk J
  13. Allin D
  14. Aljitawi OS
  Results of the First Clinical Study in Humans That Combines Hyperbaric Oxygen Pretreatment with Autologous Peripheral Blood Stem Cell Transplantation.; Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation; Vol 25(9). 2019 Sep.
• 1. Chiu YG
  2. Aljitawi OS
  VCAM-1+ macrophages usher hematopoietic stem and progenitor cell to vascular niche "hotspots".; Annals of translational medicine; Vol 7(Suppl 3). 2019 Jul.
• 1. Li D
  2. Chiu G
  3. Lipe B
  4. Hopkins RA
  5. Lillis J
  6. Ashton JM
  7. Paul S
  8. Aljitawi OS
  Decellularized Wharton jelly matrix: a biomimetic scaffold for ex vivo hematopoietic stem cell culture.; Blood advances; Vol 3(7). 2019 Apr 09.
• 1. Milito C
  2. Masel D
  3. Henrichs K
  4. Schmidt AE
  5. Kirkley S
  6. Aljitawi O
  7. Becker M
  8. Blumberg N
  9. Refaai MA
  Post-Transfusion Purpura Mimicking Idiopathic Thrombocytopenic Purpura: A Case Report.; Laboratory medicine. 2019 Mar 27.
• 1. Mina A
  2. Shune L
  3. Abdelhakim H
  4. Lin TL
  5. Ganguly S
  6. Baran A
  7. Singh A
  8. Abhyankar S
  9. McGuirk JP
  10. Allin D
  11. Aljitawi OS
  Long-term results of a pilot study evaluating hyperbaric oxygen therapy to improve umbilical cord blood engraftment.; Annals of hematology; Vol 98(2). 2019 Feb.
• 1. Li D
  2. Lin TL
  3. Lipe B
  4. Hopkins RA
  5. Shinogle H
  6. Aljitawi OS
  A novel extracellular matrix-based leukemia model supports leukemia cells with stem cell-like characteristics.; Leukemia research; Vol 72. 2018 Sep.
• 1. Converse GL
  2. Li D
  3. Buse EE
  4. Hopkins RA
  5. Aljitawi OS
  Wharton's Jelly Matrix Decellularization for Tissue Engineering Applications.; Methods in molecular biology (Clifton, N.J.); Vol 1577. 2018.
• 1. Cheung KY
  2. Berry A
  3. Li D
  4. Aljitawi OS
  Hyperbaric oxygen treatment effects on in vitro cultured umbilical cord blood CD34+ cells.; Cytotherapy; Vol 20(1). 2018 Jan.
• 1. Aljitawi OS
  2. Laughlin M
  3. Broxmeyer H
  Erythropoietin in umbilical cord blood transplantation: defining the role and implications.; Expert review of hematology; Vol 10(8). 2017 Aug.
• 1. Lipe B
  2. Kambhampati S
  3. Veldhuizen PV
  4. Yacoub A
  5. Aljitawi O
  6. Mikhael J
  Correlation between markers of bone metabolism and vitamin D levels in patients with monoclonal gammopathy of undetermined significance (MGUS).; Blood cancer journal; Vol 7(12). 2017 Jan 14.
• 1. Jadalannagari S
  2. Converse G
  3. McFall C
  4. Buse E
  5. Filla M
  6. Villar MT
  7. Artigues A
  8. Mellot AJ
  9. Wang J
  10. Detamore MS
  11. Hopkins RA
  12. Aljitawi OS
  Decellularized Wharton's Jelly from human umbilical cord as a novel 3D scaffolding material for tissue engineering applications.; PloS one; Vol 12(2). 2017.
• 1. Aljitawi O
  Erythropoietin in umbilical cord blood transplantation: Defining the role and implications; Expert Review of Hematology.. 2017 Jan 01.
• 1. Abhyankar S
  2. Lubanski P
  3. DeJarnette S
  4. Merkel D
  5. Bunch J
  6. Daniels K
  7. Aljitawi O
  8. Lin T
  9. Ganguly S
  10. McGuirk J
  A novel hematopoietic progenitor cell mobilization regimen, utilizing bortezomib and filgrastim, for patients undergoing autologous transplant.; Journal of clinical apheresis; Vol 31(6). 2016 Dec.
• 1. Jadalannagari S
  2. Berry AM
  3. Hopkins RA
  4. Bhavsar D
  5. Aljitawi OS
  Potential mechanisms underlying ectodermal differentiation of Wharton's jelly mesenchymal stem cells.; Biochemical and biophysical research communications; Vol 478(2). 2016 Sep 16.
• 1. Singh AK
  2. Porrata LF
  3. Aljitawi O
  4. Lin T
  5. Shune L
  6. Ganguly S
  7. McGuirk JP
  8. Abhyankar S
  Fatal GvHD induced by PD-1 inhibitor pembrolizumab in a patient with Hodgkin's lymphoma.; Bone marrow transplantation; Vol 51(9). 2016 Sep.
• 1. Rinehart M
  2. Hochard E
  3. Rockey M
  4. Abhyankar S
  5. Ganguly S
  6. Lin T
  7. McGuirk J
  8. Shune L
  9. Singh A
  10. Aljitawi O
  Evaluation of cytomegalovirus reactivation and tolerability in seropositive umbilical cord transplant patients after implementation of an intensive prevention strategy.; Hematology/oncology and stem cell therapy; Vol 9(3). 2016 Sep.
• 1. Brownback KR
  2. Simpson SQ
  3. Pitts LR
  4. Polineni D
  5. McGuirk JP
  6. Ganguly S
  7. Aljitawi OS
  8. Lin TL
  9. Singh A
  10. Abhyankar S
  Effect of extracorporeal photopheresis on lung function decline for severe bronchiolitis obliterans syndrome following allogeneic stem cell transplantation.; Journal of clinical apheresis; Vol 31(4). 2016 Aug.
• 1. Iliff A
  2. Divine C
  3. Diaz F
  4. Aljitawi O
  5. Abhayankar S
  6. McGuirk J
  7. Ganguly S
  Adequacy of peripheral blood stem cell mobilization in patients with relapsed B-cell non-Hodgkin lymphoma treated with bendamustine.; Leukemia & lymphoma; Vol 57(5). 2016 May.
• 1. Aljitawi OS
  2. Hari P
  Propylene glycol-free melphalan as conditioning regimen for autologous transplantation in myeloma.; International journal of hematologic oncology; Vol 5(1). 2016 May.
• 1. Luu Tran H
  2. Mahmoudjafari Z
  3. Rockey M
  4. Henry D
  5. Grauer D
  6. Aljitawi O
  7. Abhyankar S
  8. Ganguly S
  9. Lin T
  10. McGuirk J
  Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease.; Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners; Vol 22(2). 2016 Apr.
• 1. Aljitawi OS
  2. Paul S
  3. Ganguly A
  4. Lin TL
  5. Ganguly S
  6. Vielhauer G
  7. Capitano ML
  8. Cantilena A
  9. Lipe B
  10. Mahnken JD
  11. Wise A
  12. Berry A
  13. Singh AK
  14. Shune L
  15. Lominska C
  16. Abhyankar S
  17. Allin D
  18. Laughlin M
  19. McGuirk JP
  20. Broxmeyer HE
  Erythropoietin modulation is associated with improved homing and engraftment after umbilical cord blood transplantation.; Blood; Vol 128(25). 2016 Jan 22.
• 1. Pokhrel SD
  2. Persons DL
  3. Aljitawi OS
  RSV-Related Thrombocytopenia Associated with Transient Cytogenetic Abnormalities in a Recipient of Umbilical Cord Blood Transplantation.; Case reports in hematology; Vol 2016. 2016.
• 1. Kirschbaum MH
  2. Frankel P
  3. Synold TW
  4. Xie Z
  5. Yen Y
  6. Popplewell L
  7. Chen R
  8. Aljitawi O
  9. Tuscano JM
  10. Chan KK
  11. Newman EM
  A phase I pharmacodynamic study of GTI-2040, an antisense oligonucleotide against ribonuclotide reductase, in acute leukemias: a California Cancer Consortium study.; Leukemia & lymphoma; Vol 57(10). 2016 Jan.
• 1. Hari P
  2. Aljitawi OS
  3. Arce-Lara C
  4. Nath R
  5. Callander N
  6. Bhat G
  7. Allen LF
  8. Stockerl-Goldstein K
  A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation.; Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation; Vol 21(12). 2015 Dec.
• 1. Bray WM
  2. Bivona C
  3. Rockey M
  4. Henry D
  5. Grauer D
  6. Abhyankar S
  7. Aljitawi O
  8. Ganguly S
  9. McGuirk J
  10. Singh A
  11. Lin TL
  Outcomes for newly diagnosed patients with acute myeloid leukemia dosed on actual or adjusted body weight.; Cancer chemotherapy and pharmacology; Vol 76(4). 2015 Oct.
• 1. Ciurea SO
  2. Zhang MJ
  3. Bacigalupo AA
  4. Bashey A
  5. Appelbaum FR
  6. Aljitawi OS
  7. Armand P
  8. Antin JH
  9. Chen J
  10. Devine SM
  11. Fowler DH
  12. Luznik L
  13. Nakamura R
  14. O'Donnell PV
  15. Perales MA
  16. Pingali SR
  17. Porter DL
  18. Riches MR
  19. Ringdén OT
  20. Rocha V
  21. Vij R
  22. Weisdorf DJ
  23. Champlin RE
  24. Horowitz MM
  25. Fuchs EJ
  26. Eapen M
  Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia.; Blood; Vol 126(8). 2015 Aug 20.
• 1. Jadalannagari S
  2. Aljitawi OS
  Ectodermal Differentiation of Wharton's Jelly Mesenchymal Stem Cells for Tissue Engineering and Regenerative Medicine Applications.; Tissue engineering. Part B, Reviews; Vol 21(3). 2015 Jun.
• 1. Lin TL
  2. Williams T
  3. He J
  4. Aljitawi OS
  5. Ganguly S
  6. Abhyankar S
  7. Fleming A
  8. Male H
  9. McGuirk JP
  Rates of complete diagnostic testing for patients with acute myeloid leukemia.; Cancer medicine; Vol 4(4). 2015 Apr.
• 1. Ganguly S
  2. McRae J
  3. He J
  4. Divine C
  5. Abhyankar S
  6. Aljitawi O
  7. McGuirk JP
  Routine radiographic screening after completion of initial chemotherapy and relapse-free survival after transplant in patients with relapsed lymphoma.; Leukemia & lymphoma; Vol 56(2). 2015 Feb.
• 1. Singh AK
  2. Divine C
  3. Aljitawi O
  4. Abhyankar S
  5. McQuirk JP
  6. Ganguly S
  In Vivo Purging May Not be Required in the Era of Universal Use of Rituximab Containing Chemo-Immunotherapy in Patients with Follicular and Mantle Cell Lymphoma: A Single Center Experience.; Bio of Blood and Marrow Transp; Vol 21(2 Supp), pp. 135-136. 2015 Jan 01.
• 1. Aljitawi OS
  2. Ganguly S
  3. Abhyankar SH
  4. Ferree M
  5. Marks R
  6. Pipkin JD
  7. McGuirk JP
  Phase IIa cross-over study of propylene glycol-free melphalan (LGD-353) and alkeran in multiple myeloma autologous transplantation.; Bone marrow transplantation; Vol 49(8). 2014 Aug.
• 1. Deauna-Limayo D
  2. Aljitawi OS
  3. Ganguly S
  4. Abhyankar S
  5. Wick JA
  6. McGuirk JP
  Combined use of multiday palonosetron with aprepitant and low-dose dexamethasone in prevention of nausea and emesis among patients with multiple myeloma and lymphoma undergoing autologous hematopoietic stem cell transplant: A pilot study.; Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners; Vol 20(4). 2014 Aug.
• 1. Prochaska L
  2. Vacek J
  3. Madan R
  4. Abhyankar S
  5. Ganguly S
  6. McGuirk JP
  7. Lin TL
  8. Aljitawi OS
  Intestinal ischemia after allogeneic stem cell transplantation: a report of four cases.; Transplantation proceedings; Vol 46(5). 2014 Jun.
• 1. Brownback KR
  2. Simpson SQ
  3. McGuirk JP
  4. Lin TL
  5. Abhyankar S
  6. Ganguly S
  7. Aljitawi OS
  Pulmonary manifestations of the pre-engraftment syndrome after umbilical cord blood transplantation.; Annals of hematology; Vol 93(5). 2014 May.
• 1. Wieliczka ML
  2. Ganguly S
  3. Abhyankar S
  4. Lin T
  5. McGuirk JP
  6. Aljitawi OS
  Rituximab as a treatment for factor VIII inhibitor in a patient with chronic GVHD.; Bone marrow transplantation; Vol 49(4). 2014 Apr.
• 1. Aljitawi OS
  2. Li D
  3. Xiao Y
  4. Zhang D
  5. Ramachandran K
  6. Stehno-Bittel L
  7. Van Veldhuizen P
  8. Lin TL
  9. Kambhampati S
  10. Garimella R
  A novel three-dimensional stromal-based model for in vitro chemotherapy sensitivity testing of leukemia cells.; Leukemia & lymphoma; Vol 55(2). 2014 Feb.
• 1. Pawar RD
  2. Williams T
  3. Khera R
  4. Eid A
  5. Aljitawi OS
  6. Dusing RW
  Inflammatory response following neutrophil recovery postchemotherapy in acute myeloid leukemia cases without evidence of infection: role of homing of neutrophils.; Journal of blood medicine; Vol 5. 2014.
• 1. Aljitawi OS
  2. Xiao Y
  3. Eskew JD
  4. Parelkar NK
  5. Swink M
  6. Radel J
  7. Lin TL
  8. Kimler BF
  9. Mahnken JD
  10. McGuirk JP
  11. Broxmeyer HE
  12. Vielhauer G
  Hyperbaric oxygen improves engraftment of ex-vivo expanded and gene transduced human CD34⁺ cells in a murine model of umbilical cord blood transplantation.; Blood cells, molecules & diseases; Vol 52(1). 2014 Jan.
• 1. Pawar R
  2. Kasi Loknath Kumar A
  3. Woodroof J
  4. Cui W
  5. McGuirk J
  6. Abhyankar S
  7. Ganguly S
  8. Singh A
  9. Lin T
  10. Aljitawi O
  Skin Recurrence of Transformed Mycosis Fungoides Postumbilical Cord Blood Transplant despite Complete Donor Chimerism.; Case reports in hematology; Vol 2014. 2014.
• 1. Williams CB
  2. Kambhampati S
  3. Fiskus W
  4. Wick J
  5. Dutreix C
  6. Ganguly S
  7. Aljitawi O
  8. Reyes R
  9. Fleming A
  10. Abhyankar S
  11. Bhalla KN
  12. McGuirk JP
  Preclinical and phase I results of decitabine in combination with midostaurin (PKC412) for newly diagnosed elderly or relapsed/refractory adult patients with acute myeloid leukemia.; Pharmacotherapy; Vol 33(12). 2013 Dec.
• 1. Ganguly S
  2. Amin M
  3. Divine C
  4. Aljitawi OS
  5. Abhyankar S
  6. McGuirk JP
  Decitabine in patients with relapsed acute myeloid leukemia (AML) after allogeneic stem cell transplantation (allo-SCT).; Annals of hematology; Vol 92(4). 2013 Apr.
• 1. Alhafez A
  2. Aljitawi OS
  3. Lin TL
  4. Ganguly S
  5. Abhyankar S
  6. McGuirk JP
  Bendamustine associated with irreversible ascending paralysis.; Case reports in hematology; Vol 2013. 2013.
• 1. Aljitawi OS
  2. Xiao Y
  3. Zhang D
  4. Stehno-Bittel L
  5. Garimella R
  6. Hopkins RA
  7. Detamore MS
  Generating CK19-positive cells with hair-like structures from Wharton's jelly mesenchymal stromal cells.; Stem cells and development; Vol 22(1). 2013 Jan 01.
• 1. Williams T
  2. Aljitawi OS
  3. Moussa R
  4. McHugh S
  5. Dusing R
  6. Abraha J
  7. Yarlagadda SG
  First case of donor transmitted non-leukemic promyelocytic sarcoma.; Leukemia & lymphoma; Vol 53(12). 2012 Dec.
• 1. Aljitawi OS
  2. Coats A
  3. Zhang D
  4. Ganguly S
  5. Abhyankar S
  6. Lin T
  7. McGuirk JP
  Umbilical cord graft-versus-leukemia effect induces remission without the price of graft-versus-host disease: the possible role of NK cells.; Clinical transplantation; Vol 26(5). 2012 Sep.